Medication info
Memantine Tablets 10 mg (Memantine Hydrochloride)

Memantine Tablets 10 mg (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Teragen Etex Co., Ltd.
Appearance
White oblong film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201507906 · Approved 2015.11.25 · Insurance code 698505000

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
Treatment must be initiated by a physician experienced in the diagnosis and treatment of Alzheimer's dementia, and only if a caregiver can periodically confirm that the patient is taking the medicine. Diagnosis should be made according to currently accepted guidelines. The clinical benefit of this medicine and the patient's tolerability of treatment should be reassessed periodically. This medicine is administered orally once daily, at the same time each day. If necessary, this medicine may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20 mg. To minimize the risk of adverse reactions, increase the dose by 5 mg per week over the first 3 weeks as follows, until the maintenance dose is reached. First week (Days 1–7) Administer 5 mg daily for 7 days. Second week (Days 8–14) Administer 10 mg daily for 7 days. Third week (Days 15–21) Administer 15 mg daily for 7 days. From the fourth week onward Administer 20 mg daily. Maintenance dose: The recommended maintenance dose is 20 mg daily. 2. Elderly patients: Based on clinical data, the recommended dose for elderly patients aged 65 years and older is 20 mg daily. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10 mg. If well tolerated, the dose may be increased to 20 mg daily at least 7 days after starting treatment, following the standard dose-escalation method. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10 mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Ingredients

Manufacturer
Teragen Etex Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used to treat moderate to severe Alzheimer's disease. Alzheimer's disease is a neurodegenerative condition that causes a decline in memory and cognitive functions, and this drug helps slow the progression of symptoms and improve the patient's ability to perform daily activities. Positive effects on maintaining cognitive function and alleviating behavioral symptoms can be expected with its use.

How to take

Adult dose

Treatment must be initiated by a physician experienced in the diagnosis and treatment of Alzheimer's dementia, and only if a caregiver can periodically confirm that the patient is taking the medicine. Diagnosis should be made according to currently accepted guidelines. The clinical benefit of this medicine and the patient's tolerability of treatment should be reassessed periodically. This medicine is administered orally once daily, at the same time each day. If necessary, this medicine may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20 mg. To minimize the risk of adverse reactions, increase the dose by 5 mg per week over the first 3 weeks as follows, until the maintenance dose is reached. First week (Days 1–7) Administer 5 mg daily for 7 days. Second week (Days 8–14) Administer 10 mg daily for 7 days. Third week (Days 15–21) Administer 15 mg daily for 7 days. From the fourth week onward Administer 20 mg daily. Maintenance dose: The recommended maintenance dose is 20 mg daily. 2. Elderly patients: Based on clinical data, the recommended dose for elderly patients aged 65 years and older is 20 mg daily. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10 mg. If well tolerated, the dose may be increased to 20 mg daily at least 7 days after starting treatment, following the standard dose-escalation method. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10 mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Precautions

This drug should not be used in patients with hypersensitivity to its ingredients. It is also advisable not to administer this medication to patients with severely impaired liver function or very poor kidney function. Caution is warranted in patients with epilepsy or those who have experienced seizures in the past. In particular, co-administration with NMDA antagonists such as amantadine, ketamine, or dextromethorphan may increase the risk of side effects, and such combinations should be avoided. Patients experiencing changes in urinary acidity or consuming a lot of alkaline beverages should also take care. The safety of this drug in patients with a history of myocardial infarction, congestive heart failure, or uncontrolled hypertension has not been sufficiently established, so it should be used cautiously. While taking this drug, side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur, and if symptoms are severe, consultation with a physician is advised. Rarely, neurological symptoms such as mental confusion, hallucinations, or seizures may occur, so caution is warranted. There may be interactions with other medications, so especially when taking antipsychotics, muscle relaxants, or anticoagulants, patients should definitely consult with a doctor or pharmacist. Women who are pregnant or may become pregnant should carefully consider the risks and benefits before taking this medication, and breastfeeding women are advised to discontinue breastfeeding while taking this drug. The safety and efficacy of this medication in children or adolescents under 18 years old have not been established, and its use is not recommended. In cases of overdose, serious symptoms such as coma, hallucinations, or seizures may occur, and in such cases, immediate medical attention should be sought. This drug may affect the central nervous system, so caution should be exercised when driving or operating machinery. Keep this product out of reach of children, and do not transfer it to another container.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • confusion
  • hallucination
  • psychotic reaction
Show 21 more
  • balance disorder
  • gait abnormalities
  • seizure
  • heart failure
  • venous thromboembolism/thrombosis
  • dyspnea
  • vomiting
  • pancreatitis
  • elevated liver function test results
  • hepatitis
  • fatigue
  • abnormal drowsiness
  • anxiety
  • aggression
  • stupor
  • unconsciousness
  • restlessness
  • psychosis
  • visual disturbances
  • coma
  • double vision

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

White oblong film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.